Radiotherapy Versus Radiotherapy Combined With Temozolomide in High-risk Low-grade Gliomas After Surgery
Clinical trial NCT04316039 · RECRUITING
Trial details
- NCT number
- NCT04316039
- Sponsor
- West China Hospital
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-10
- Primary completion
- 2023-04-10
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.